Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,018,434
-
Share change
-
-604,351
-
Total reported value
-
$10,637,148
-
Price per share
-
$2.12
-
Number of holders
-
21
-
Value change
-
-$1,402,730
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q4 2018
As of 31 Dec 2018,
ZOSANO PHARMA CORP - COM NEW (ZSAN) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,018,434 shares.
The largest 10 holders included
Aisling Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., NEXTHERA CAPITAL LP, HealthCor Management, L.P., Telemetry Investments, L.L.C., MORGAN STANLEY, Vanguard Group Inc, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Lombard Odier Asset Management (USA) Corp.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.